X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-15 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale+OE | $20.70 | -42,604 | 284,442 | -13% | -$882,110 | |||||
2024-11-12 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $26.34 | -123 | 317,046 | 0% | -$3,240 | ||||||
2024-10-30 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $23.15 | -547 | 317,169 | 0% | -$12,663 | ||||||
| DM | 2024-10-15 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale+OE | $23.23 | -20,000 | 317,716 | -6% | -$464,500 | |||||
| DM | 2024-09-18 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale+OE | $24.69 | -20,000 | 317,716 | -6% | -$493,700 | |||||
| M | 2024-07-11 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $23.32 | -767 | 317,716 | 0% | -$17,888 | |||||
2024-05-29 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $21.78 | -517 | 318,483 | 0% | -$11,260 | ||||||
2024-05-17 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $22.18 | -98 | 319,000 | 0% | -$2,174 | ||||||
2024-04-18 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $15.31 | -584 | 319,098 | 0% | -$8,941 | ||||||
2024-03-27 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $17.99 | -454 | 319,682 | 0% | -$8,167 | ||||||
| M | 2024-03-11 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $16.64 | -6,834 | 320,136 | -2% | -$113,701 | |||||
2024-02-21 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $17.35 | -101 | 275,214 | 0% | -$1,752 | ||||||
2024-01-19 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $16.76 | -1,450 | 275,315 | -1% | -$24,302 | ||||||
2024-01-02 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $16.75 | -697 | 276,765 | 0% | -$11,675 | ||||||
2023-12-01 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $12.37 | -591 | 275,961 | 0% | -$7,311 | ||||||
2023-11-13 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $10.77 | -132 | 275,726 | 0% | -$1,422 | ||||||
2023-09-28 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $14.16 | -659 | 273,121 | 0% | -$9,331 | ||||||
2023-08-25 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $10.99 | -519 | 271,220 | 0% | -$5,704 | ||||||
2023-08-14 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $12.38 | -180 | 271,739 | 0% | -$2,228 | ||||||
| DM | 2023-07-19 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale+OE | $20.27 | -20,000 | 271,919 | -7% | -$405,300 | |||||
2023-06-27 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $22.91 | -695 | 271,919 | 0% | -$15,922 | ||||||
| DM | 2023-06-21 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale+OE | $23.15 | -20,000 | 272,614 | -7% | -$462,900 | |||||
2023-05-31 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $23.21 | -504 | 272,614 | 0% | -$11,698 | ||||||
| DM | 2023-05-24 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale+OE | $22.24 | -20,000 | 273,118 | -7% | -$444,700 | |||||
2023-05-15 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $18.71 | -125 | 273,118 | 0% | -$2,339 | ||||||
| AD | 2023-04-06 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale+OE | $20.03 | -2,093 | 273,243 | -1% | -$41,923 | |||||
| DM | 2023-04-19 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale+OE | $19.36 | -20,000 | 268,352 | -7% | -$387,200 | |||||
2023-04-06 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $20.03 | -2,093 | 268,352 | -1% | -$41,923 | ||||||
2023-03-29 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $20.62 | -741 | 270,445 | 0% | -$15,279 | ||||||
| DM | 2023-03-22 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale+OE | $21.62 | -20,000 | 271,186 | -7% | -$432,300 | |||||
2023-03-07 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $22.95 | -415 | 271,186 | 0% | -$9,524 | ||||||
2023-03-01 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $22.75 | -2,086 | 271,601 | -1% | -$47,457 | ||||||
2023-02-09 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $24.60 | -78 | 273,687 | 0% | -$1,919 | ||||||
| DM | 2023-02-01 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale+OE | $23.86 | -20,000 | 273,765 | -7% | -$477,160 | |||||
| DM | 2023-01-03 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale+OE | $18.11 | -20,000 | 252,826 | -7% | -$362,255 | |||||
2022-12-28 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $16.90 | -712 | 252,826 | 0% | -$12,033 | ||||||
2022-11-29 | BLFS | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $19.93 | -436 | 253,538 | 0% | -$8,689 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |